(AP) -- GlaxoSmithKline PLC on Wednesday applied for approval in the U.S. and Europe to sell an existing breast-cancer drug as a first-line treatment.
Full article >>
Subscribe to:
Post Comments (Atom)
News about cancer from less common areas of the web. Updated daily.
(AP) -- GlaxoSmithKline PLC on Wednesday applied for approval in the U.S. and Europe to sell an existing breast-cancer drug as a first-line treatment.
Full article >>
No comments:
Post a Comment